Eli Lilly and Co

Kramer’s Lightning Round;

As the debt ceiling talks drag on, defense stocks should be strong

Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

With the debt crisis looming, check out these names and sectors

LLY hits new high after drug study. How the pros are playing it

Eli Lilly’s Donumab treatment slowed the progression of the disease

With the debt ceiling on the market, look to 2011

EIi Lilly’s weight-loss drug is ‘much better’ than others on the market, says Wells Fargo’s Bansal

Jim Cramer’s Top 10 Things to Watch in the Stock Market Friday

Eli Lilly weight loss drug tirzepatide data released

Big Tech Earnings, Crucial Inflation Call: Biggest Week of the Season

Treasury yields remained largely unchanged as the focus remained on the economic outlook and earnings.